23 related articles for article (PubMed ID: 33929088)
1. The SMAC mimetic GDC-0152 is a direct ABCB1-ATPase activity modulator and BIRC5 expression suppressor in cancer cells.
Lin IL; Lin YT; Chang YC; Kondapuram SK; Lin KH; Chen PC; Kuo CY; Coumar MS; Cheung CHA
Toxicol Appl Pharmacol; 2024 Apr; 485():116888. PubMed ID: 38452945
[TBL] [Abstract][Full Text] [Related]
2. Novel pyxinol amide derivatives bearing an aliphatic heterocycle as P-glycoprotein modulators for overcoming multidrug resistance.
Yu L; Ren R; Li S; Zhang C; Chen C; Lv H; Zou Z; Pei X; Song Z; Zhang P; Wang H; Yang G
Eur J Med Chem; 2024 Jun; 272():116466. PubMed ID: 38704938
[TBL] [Abstract][Full Text] [Related]
3. 4-{3-[(Pyridin-4-ylmethyl)amino]-[1,2,4]triazolo[4,3-b][1,2,4]triazin-6-yl}phenol: An improved anticancer agent in hepatocellular carcinoma and a selective MDR1/MRP modulator.
Khatir ZZ; Di Sotto A; Percaccio E; Tuylu Kucukkilinc T; Ercan A; Chippindale AM; Valipour M; Irannejad H
Arch Pharm (Weinheim); 2024 Jun; 357(6):e2300704. PubMed ID: 38442326
[TBL] [Abstract][Full Text] [Related]
4. 6,7-Dimethoxy-2-phenethyl-1,2,3,4-tetrahydroisoquinoline amides and corresponding ester isosteres as multidrug resistance reversers.
Braconi L; Bartolucci G; Contino M; Chiaramonte N; Giampietro R; Manetti D; Perrone MG; Romanelli MN; Colabufo NA; Riganti C; Dei S; Teodori E
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):974-992. PubMed ID: 32253945
[TBL] [Abstract][Full Text] [Related]
5. Synthetic and Biological Studies of Sesquiterpene Polygodial: Activity of 9-Epipolygodial against Drug-Resistant Cancer Cells.
Dasari R; De Carvalho A; Medellin DC; Middleton KN; Hague F; Volmar MN; Frolova LV; Rossato MF; De La Chapa JJ; Dybdal-Hargreaves NF; Pillai A; Mathieu V; Rogelj S; Gonzales CB; Calixto JB; Evidente A; Gautier M; Munirathinam G; Glass R; Burth P; Pelly SC; van Otterlo WA; Kiss R; Kornienko A
ChemMedChem; 2015 Dec; 10(12):2014-26. PubMed ID: 26434977
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Novel Benzo-annelated 1,4-dihydropyridines as MDR Modulators in Cancer Cells.
Werner P; Szemeredi N; Spengler G; Hilgeroth A
Anticancer Agents Med Chem; 2024 May; ():. PubMed ID: 38706362
[TBL] [Abstract][Full Text] [Related]
7. Nitrogen-containing andrographolide derivatives with multidrug resistance reversal effects in cancer cells.
Ribeiro JRL; Szemerédi N; Gonçalves BMF; Spengler G; Afonso CAM; Ferreira MU
RSC Med Chem; 2024 Apr; 15(4):1348-1361. PubMed ID: 38665830
[TBL] [Abstract][Full Text] [Related]
8. Molecular Modeling Studies to Probe the Binding Hypothesis of Novel Lead Compounds against Multidrug Resistance Protein ABCB1.
Cheema Y; Linton KJ; Jabeen I
Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254714
[TBL] [Abstract][Full Text] [Related]
9. Identification and Empiric Evaluation of New Inhibitors of the Multidrug Transporter P-Glycoprotein (ABCB1).
Cheema Y; Kiani YS; Linton KJ; Jabeen I
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982374
[TBL] [Abstract][Full Text] [Related]
10. Bipiperidinyl derivatives of 23-hydroxybetulinic acid reverse resistance of HepG2/ADM and MCF-7/ADR cells.
Zhang DM; Li YJ; Shu C; Ruan ZX; Chen WM; Yiu A; Peng YH; Wang J; Lan P; Yao Z; Fung KP; Fu LW; Chen ZS; Ye WC
Anticancer Drugs; 2013 Jun; 24(5):441-54. PubMed ID: 23466650
[TBL] [Abstract][Full Text] [Related]
11. Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators.
Dei S; Braconi L; Trezza A; Menicatti M; Contino M; Coronnello M; Chiaramonte N; Manetti D; Perrone MG; Romanelli MN; Udomtanakunchai C; Colabufo NA; Bartolucci G; Spiga O; Salerno M; Teodori E
Eur J Med Chem; 2019 Jun; 172():71-94. PubMed ID: 30947123
[TBL] [Abstract][Full Text] [Related]
12. Computer-Aided Search for 5-Arylideneimidazolone Anticancer Agents Able To Overcome ABCB1-Based Multidrug Resistance.
Kaczor A; Szemerédi N; Kucwaj-Brysz K; Dąbrowska M; Starek M; Latacz G; Spengler G; Handzlik J
ChemMedChem; 2021 Aug; 16(15):2386-2401. PubMed ID: 33929088
[TBL] [Abstract][Full Text] [Related]
13. Search for ABCB1 Modulators Among 2-Amine-5-Arylideneimidazolones as a New Perspective to Overcome Cancer Multidrug Resistance.
Kaczor A; Nové M; Kincses A; Spengler G; Szymańska E; Latacz G; Handzlik J
Molecules; 2020 May; 25(9):. PubMed ID: 32403277
[TBL] [Abstract][Full Text] [Related]
14. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo.
Zhang Z; Ma C; Li P; Wu M; Ye S; Fu L; Xu J
Cell Commun Signal; 2019 Sep; 17(1):110. PubMed ID: 31472682
[TBL] [Abstract][Full Text] [Related]
15. Discovery of phenylselenoether-hydantoin hybrids as ABCB1 efflux pump modulating agents with cytotoxic and antiproliferative actions in resistant T-lymphoma.
Ali W; Spengler G; Kincses A; Nové M; Battistelli C; Latacz G; Starek M; Dąbrowska M; Honkisz-Orzechowska E; Romanelli A; Rasile MM; Szymańska E; Jacob C; Zwergel C; Handzlik J
Eur J Med Chem; 2020 Aug; 200():112435. PubMed ID: 32505850
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
